News

Missing Information Can Misinform

In the online attention economy, new research from the UC San Diego Rady School finds that making science more clickable or shareable can help some readers learn more – but leaves many others with an […]

No Picture
News

Cubit Diagnostics Closes SAFE Financing to Advance Molecular Assay Development and Expand Immunoassay Menu

CARLSBAD, Calif.–(BUSINESS WIRE)–Cubit Diagnostics today announced it has closed its latest round of SAFE (Simple Agreement for Future Equity) financing. The proceeds will fund the company’s next phase of work, centered on locking in design […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

SAN DIEGO–(BUSINESS WIRE)–Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the pricing of its underwritten offering of $475.0 million aggregate principal amount of 0.50% convertible senior notes due 2032 (the “Notes”). The sale of the Notes […]

News

Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the first quarter ended March 31, 2026. “Acadia delivered a solid first quarter of 2026 with total revenues of $268 million, driven […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

SAN DIEGO–(BUSINESS WIRE)–Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced its intention to offer, subject to market and other conditions, $400 million aggregate principal amount of convertible senior notes due 2032 (the “Notes”) in an underwritten […]


ADVERTISEMENT — Advertise With Biotech Networks
News

QuidelOrtho Reports First Quarter 2026 Financial Results

? LEX Diagnostics Acquisition Expected to Accelerate Growth in Point-of-Care Molecular Diagnostics ? ? Key Product Launches in U.S. and International Markets Expected to Drive Future Growth ? ? Company Updates Full-Year 2026 Financial Guidance […]

No Picture
News

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and L?kahi Therapeutics to Advance Apitox Program

MATAWAN, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) today announced a comprehensive settlement with Inscobee Inc. and Apimeds Inc. (the “Inscobee Parties”), resolving all outstanding disputes arising from the APUS’ […]

News

Sanford Burnham Prebys Medical Discovery Institute receives $5 million from Qualcomm co-founder Andrew Viterbi to advance AI-powered research

LA JOLLA, Calif., May 5, 2026 /PRNewswire/ — Sanford Burnham Prebys Medical Discovery Institute today announced that Andrew Viterbi, a visionary communications pioneer and co-founder of Qualcomm Inc., has made a $5 million gift to […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Epirium Bio Presenting New Preclinical Data on its 15-PGDH Inhibitor Program in Inflammatory Bowel Disease at Digestive Disease Week® 2026

SAN DIEGO–(BUSINESS WIRE)–Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral 15-PGDH inhibitor program in inflammatory bowel disease (IBD), including […]

News

Senhwa Biosciences Launches Global Study, Targeting Breakthrough in Hard-to-Treat Cancers with CX-5461 and Tislelizumab Combination

TAIPEI and SAN DIEGO, May 5, 2026 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company today announced the initiation of a global, multi-center clinical trial. The Company has also submitted an Investigational […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today announced that 36-month results from patients […]

News

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-‘2118, a Corticotropin-Releasing Factor Type 2 Receptor Agonist

NBIP-‘2118 targets a new, non-incretin mechanism for weight loss with lean mass preservation SAN DIEGO, May 4, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 1 first-in-human clinical […]

No Picture
News

Biotheryx to Present Results from its Phase 1A Dose Escalation Study of BTX-9341 for the Treatment of HR+/HER2- Breast Cancer at the 2026 European Society for Medical Oncology Breast Cancer Annual Congress

SAN DIEGO, May 4, 2026 /PRNewswire/ — Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, today announced that data from its Phase 1A […]


ADVERTISEMENT — Advertise With Biotech Networks
News

ImpediMed Broadens Breast Cancer Survivorship Monitoring with the SOZO® Digital Health Platform at ASBrS 2026

Pivotal posters at ASBrS 2026 highlight body composition monitoring, BIS, and lymphedema surveillance in breast cancer care CARLSBAD, Calif., May 1, 2026 /PRNewswire/ — ImpediMed, a leader in medical technologies to clinically monitor and manage […]


ADVERTISEMENT — Advertise With Biotech Networks